ReviewClinical cardiology2018
PCSK9 inhibitor valuation: A science-based review of the two recent models.
Seth J Baum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewClinical cardiology2018
Seth J Baum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.